NCT00824057View on ClinicalTrials.gov

Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 31, 2009

Study Completion Date

March 31, 2009

Conditions

Healthy

Interventions

DRUG

AZD6280

oral

DRUG

Midazolam

oral

DRUG

Caffeine

oral

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY